Surgical and clinical parameters of the patients with relapsed ovarian cancer
| Surgery Period Patient# | CRS+HIPEC 2018 P1 | 2018 P2 | 2019 P3 | 2019 P4 | 2019 P5 | CRS 2009–2018 n=63 M±St dev | |
|---|---|---|---|---|---|---|---|
| PCI/Albumin preoperative | 4/43 | 16/35 | 3/36 | 30/35 | 5/37 | 15±9,8 34,4±4,8 | |
| Surgery time/Bleeding | 300/350 | 506/100 | 585/955 | 575/900 | 310/450 | 320,5±127,4 653,2±522,1 | |
| Surgical complexity score | 4 | 12 | 2 | 11 | 6 | 7,6±3,8 | |
| Time to adjuvant chemotherapy | 4 | 4 | 6 | 6 | 4 | 4,4±1,2 | |
| Clavien-Dindo >3 | 0 | 0 | 0 | 3b | 0 | 9 (14,3%) | |
| Cytoreduction score | 0 | 0 | 0 | 1 | 0 | 63 (100%) | |
| Nausea | moderate | light | 0 | moderate | 0 | 0 | |
| Creatinin elevation | 0 | 0 | 0 | 0 | 0 | 0 | |
| Neutropenia | 0 | 0 | 0 | 0 | 0 | 0 | |